Metabiomics Colon Cancer Clinical Research Study
Palabras clave
Abstracto
Descripción
The purpose of this study is to conduct clinical research to investigate the association of the gut microbiome with colonic neoplasia. In this case several types of gut microbiome samples will be collected from patients undergoing colectomy for colonic adenocarcinoma; those samples will be tested by Metabiomics Colon Polyp and Colorectal Cancer Assay and the percentage of false negative (test returns a negative for cancer) results determined.
fechas
| Verificado por última vez: | 07/31/2018 |
| Primero enviado: | 05/26/2014 |
| Inscripción estimada enviada: | 05/26/2014 |
| Publicado por primera vez: | 05/29/2014 |
| Última actualización enviada: | 08/13/2018 |
| Última actualización publicada: | 08/14/2018 |
| Fecha de inicio real del estudio: | 02/28/2019 |
| Fecha estimada de finalización primaria: | 02/29/2020 |
| Fecha estimada de finalización del estudio: | 08/31/2020 |
Condición o enfermedad
Fase
Grupos de brazos
| Brazo | Intervención / tratamiento |
|---|---|
| Diagnosed colon cancer patients Patients undergoing colectomy for colonic adenocarcinoma. |
Criterio de elegibilidad
| Edades elegibles para estudiar | 18 Years A 18 Years |
| Sexos elegibles para estudiar | All |
| Método de muestreo | Non-Probability Sample |
| Acepta voluntarios saludables | si |
| Criterios | Inclusion Criteria: - Recently diagnosed with colorectal cancer (CRC) and scheduled for colectomy - Male or female, - Age: 18-95 years, - Able to comprehend, sign, and date the written informed consent form (ICF), - Able to give informed consent in English - Women and minorities will be included. Exclusion Criteria: - History of Inflammatory Bowel Disease - Antibiotics within 2 weeks of sample collection. - Colonoscopy, colon prep or bowel contrast agent within 7 days prior to sample collection - Any radiation therapy |
Salir
Medidas de resultado primarias
1. False negative rate of test for colon cancer [immediately post surgery]
